Cancer prevention report finds US smoking rates continue to fall but HPV vaccination rates stall
The prevalence of people smoking fell from about 14% in 2019 to 11% in 2023, according to the report published Wednesday in the journal Cancer Epidemiology, Biomarkers & Prevention. Cigarette smoking is known to significantly increase the risk of developing cancer. It's estimated to cause about 1 out of every 3 cancer deaths in the US.
'These latest findings are encouraging, mainly the reduction in smoking rates and screening for certain cancers, but it's clear urgent efforts are needed to address lagging cervical cancer prevention,' Dr. Priti Bandi, scientific director of cancer risk factors and screening surveillance research at the American Cancer Society and lead author of the study, said in a news release.
The prevalence of people being up-to-date on recommended cervical cancer screenings has dropped from 74.8% in 2019 to 73.4% in 2021 among ages 21 to 65, the report found, leaving more women at risk of not detecting disease early. The reported noted that the decrease is alarming as HPV vaccination rates have remained 'statistically unchanged' in recent years. In 2023, 61.4% of adolescents ages 13 to 17 were up-to-date for the HPV vaccination series, similar to 61.7% in 2021 and up from 54.2% in 2019.
HPV or human papillomavirus is a group of more than 150 viruses that can cause certain types of cancer. Spread primarily through sexual contact, most cases of HPV clear on their own within two years, but when the infection does not go away, health problems like cancer may occur – which is why preventing these infections with vaccination has been key.
The new report included data on US adults and their modifiable cancer risk factors in the years during and after the Covid-19 pandemic compared with the years prior to the pandemic. The data came from sources at the US Centers for Disease Control and Prevention, including the CDC's National Health Interview Survey, the Behavioral Risk Factor Surveillance System, the National Health and Nutrition Examination Survey and the National Immunization Survey-Teen.
It's estimated that nearly half – about 40% – of new cancer cases among US adults ages 30 and older could be attributed to preventable risk factors, such as cigarette smoking, excess body weight, an unhealthy diet, not exercising regularly, ultraviolet radiation exposure and cancer-causing infections like HPV.
'Despite historic reductions in smoking levels and improvements in breast and colorectal cancer screenings, including following the COVID-19 pandemic, obesity rates remain high and unchanged, physical activity levels remain suboptimal, and HPV vaccination levels have plateaued since 2021,' the American Cancer Society researchers wrote in the new report. They added that racial disparities in cancer rates and deaths persist as marginalized groups face barriers accessing healthcare.
Staying up-to-date on cancer screenings can further prevent thousands of additional cancer cases and deaths, according to the American Cancer Society.
A separate report released Monday found that the rate of people dying from cancer has stayed on a steady decline in the US from 2001 through 2022. But when it comes to the rate of people being diagnosed with cancer, the incidence rate among men fell from 2001 through 2013 and then stabilized through 2021, while incidence among women increased slightly every year between 2003 and 2021.
Those trends were interrupted in 2020, when cancer incidence rates fell significantly, possibly because of disruptions in cancer screenings and medical care related to the Covid-19 pandemic, according to the Annual Report to the Nation on the Status of Cancer published in the journal Cancer. After 2020, they returned to expected levels.
Sustained declines in lung cancer have been a major contributor to the overall improvements in cancer death rates in the US. Fewer people in the US are using tobacco, helping lower incidence and death rates for smoking-related cancers like lung, bladder and larynx, the report said.
However, incidence rates are on the rise for several other cancers, including those linked with excess weight, such as pancreas and kidney cancers; uterine, breast and liver cancers among women; and colon and rectal cancers among adolescents and young adults.
CNN's Katherine Dillinger contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
40 minutes ago
- Medscape
Rural Parents See More Care Gaps and Delays After Pregnancy
TOPLINE: Parents in the year following birth residing in rural areas experienced more healthcare barriers, including reduced access to obstetric care and increased emergency department visits, than their urban counterparts. While infant care was similar between rural and urban areas, postpartum parents reported delays in medical care compared with their infants in both settings. METHODOLOGY: Researchers conducted a cross-sectional analysis using data from the National Health Interview Survey to examine rural-urban differences in healthcare access in postpartum parents and infants. They included nonpregnant women aged 18-49 years who had infants aged 1 year or younger. A total of 2019 postpartum parents (mean age, 27.1 years) and 2191 infants residing in rural areas, and 12,112 postpartum parents (mean age, 29.2 years) and 13,088 infants residing in urban areas were included in the study. Self-rated health was assessed on a five-point scale ranging from excellent to poor for both postpartum parents and infants. Healthcare utilization was evaluated based on the location where the care was received, the number of office or emergency department visits in the prior year, visits to specific clinicians, and the number of hospitalizations. Barriers to care were categorized into insurance coverage issues (such as gaps in coverage, losing coverage after pregnancy, or changes in care location) and reasons for delayed medical care. TAKEAWAY: Parents residing in rural areas were less likely to see an obstetrician-gynecologist (P = .002), visited the emergency department more frequently (P = .030), and had more hospitalizations (P = .041) than those residing in urban areas. Parents residing in rural areas experienced more disruptions in medical care, gaps in insurance coverage, and loss of Medicaid coverage after pregnancy than their urban counterparts. Delays in medical care were also more prevalent among parents residing in rural vs urban areas (20.3% vs 15.8%; P = .009); this pattern was not observed among infants. Among both rural and urban parent-infant dyads, adults were more likely to experience uninsurance and delayed medical care than their infants. Cost was a more common reason for delayed care among postpartum parents than among infants in the same household, regardless of where they lived. IN PRACTICE: 'Investments in rural health care infrastructure may support rural families,' the authors wrote. 'Integrating and incentivizing care for postpartum parents alongside their infants may address differential use and access to care in this critical period.' SOURCE: The study was led by Sara C. Handley, MD, MSCE, of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. It was published online on August 3, 2025, in The Journal of Rural Health. LIMITATIONS: The analysis did not include specific weighting to represent the US population of parent-infant dyads. The cross-sectional design did not specify the age of the infant, which could have affected the reported number of visits and limited comments on completeness of the care. DISCLOSURES: The study received support through grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the University of Minnesota Foundation Rural Health Research Center Fund, and the Federal Office of Rural Health Policy. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


The Hill
4 hours ago
- The Hill
Former Surgeon General on HHS cancelling vaccine research: ‘Over 2 million lives have been saved because of mRNA technology'
Former U.S. Surgeon General Jerome Adams on Sunday pushed back against the Department of Health and Human Services (HHS) recently winding down its mRNA vaccine development activities via the Biomedical Advanced Research and Development Authority (BARDA). 'I want to ask you about health policy because days earlier, Secretary Kennedy made an announcement that the U.S. is halting $500 million for vaccine research into that technology known as mRNA. You're very familiar with it because it was used during Operation Warp Speed to very quickly get that COVID vaccine,' CBS's Margaret Brennan said on 'Face the Nation.' 'Secretary Kennedy said, though, mRNA vaccines, quote, 'don't work against upper respiratory infections.' Do you know what he means? And what does stopping this research do for pandemic preparations?' she added. 'Well, that's simply not true. We know that — that by the most conservative estimates over two million lives have been saved because of mRNA technology. It helped us develop COVID-19 vaccines in record time. And it's, quite frankly, President Trump's greatest achievement,' Adams replied. HHS announced last Tuesday that it was winding down the BARDA mRNA vaccine development activities. 'We reviewed the science, listened to the experts, and acted,' HHS Secretary Robert F. Kennedy Jr. said in a previous statement. The reduction of the mRNA vaccine development activities features the ending of contracts with a total worth of nearly $500 million. 'BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate,' Kennedy said.


USA Today
6 hours ago
- USA Today
Trump's ex-surgeon general slams RFK Jr.'s vaccine cuts: 'People are going to die'
"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with CBS News on Aug. 10. President Donald Trump's former surgeon general, Dr. Jerome Adams, has a stark warning about the potential ramifications of Health and Human Services Secretary Robert F. Kennedy Jr. canceling funding for mRNA vaccine development. "People are going to die because we're cutting short funding for this technology," Adams said in a CBS interview Aug. 10. Adams served from 2017 through the end of Trump's first term, when the administration helped develop mRNA vaccines to combat COVID-19 through Operation Warp Speed. Adams described the initiative as Trump's greatest achievement "bar none" and said it's concerning that his administration is turning away from the mRNA technology. Messenger RNA, or mRNA, is used in the two most common COVID-19 vaccines licensed in the United States. Adams, citing other experts, said it would've taken 18 to 24 months longer to develop the vaccines without the technology. "By the most conservative estimates, at least 2 million lives were saved," Adams said. "Many people say that up to 20 million lives were saved because of the vaccines." In a video posted on X Aug. 5, Kennedy said the decision to cut funding for mRNA vaccine development will impact 22 projects worth nearly $500 million at the Biomedical Advanced Research and Development Authority, which helps companies develop medical supplies to address public health threats. Kennedy called the vaccine technology "ineffective," which Adams said is "simply not true." Kennedy is a long-time vaccine skeptic who has been making sweeping changes to reshape vaccines, food, and medicine policies as the nation's top public health official. Adams also faulted Kennedy's response to the Aug. 8 shooting at the U.S. Centers for Disease Control and Prevention headquarters in Atlanta that claimed the life of a police officer, saying his rhetoric about vaccines was "fanning the flames that lead to situations like we saw at the CDC." Authorities identified Georgia resident Patrick Joseph White, 30, as the shooter. White's neighbor, Nancy Hoalst, told the New York Times that White believed vaccines had hurt him. "We have to understand people are listening," Adams said of Kennedy's rhetoric. "And when you call the CDC a cesspool... when you make claims that have been proven false time and time again about safety and efficacy of vaccines, that can cause unintended consequences." The Department of Health and Human Services didn't immediately respond to a request for comment about Adams' remarks. Kennedy said in an email to HHS staff Aug. 9 that the shooting "is a reminder of the very human challenges public servants sometimes face — even in places dedicated to healing and progress." "But it also reinforces the importance of the work you do every day," he added. Contributing: Adrianna Rodriguez and Ken Alltucker, USA TODAY; Reuters